HealthTech

FlowWorks

FlowWorks Raises $40M Series B to Transform HealthTech

$40M Series B
Total Raised
Series
Latest Round
2019
Founded
100-250
Employees
Palo Alto, CA
1 min read

Quick Facts

Valuation
$500M
Latest Round Size
$40M Series B
Latest Round Date
October 2025

FlowWorks Raises $40M Series B in Latest Funding Round

FlowWorks has successfully closed a $40M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by General Catalyst, with participation from Index Ventures.

Company Overview

Founded in 2019 and headquartered in Palo Alto, CA, FlowWorks has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI

With a current valuation of $500M, the company has demonstrated strong market traction and investor confidence.

Investment Details

  • Amount Raised: $40M Series B
  • Valuation: $500M
  • Lead Investor: General Catalyst

Future Outlook

As FlowWorks moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.

Key Investors

General Catalyst
Venture Capital
Leading venture capital firm investing in technology companies
Index Ventures
Venture Capital
Leading venture capital firm investing in technology companies

About the Author

Michael Torres
Michael Torres
Former startup founder turned investment analyst, focusing on early-stage technology and consumer companies.